Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Viremia D014766 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Bronchiectasis D001987 7 associated lipids
Anthrax D000881 1 associated lipids
Heart Injuries D006335 6 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Bussolati B et al. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. 1998 J. Immunol. pmid:9686616
da Silva MB et al. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. 1998 Vet. Res. Commun. pmid:9686442
Peçanha EP et al. Synthesis and pharmacological evaluation of a new class of bicyclic phospholipids, designed as platelet activating factor antagonists. 1998 Farmaco pmid:9679282
Barber LA et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. 1998 J. Biol. Chem. pmid:9668065
Tuder RM and Voelkel NF Pulmonary hypertension and inflammation. 1998 J. Lab. Clin. Med. pmid:9665367
Manya H et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. 1998 J. Biol. Chem. pmid:9660828
Akisü M et al. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice. n-3 fatty acids alter platelet-activating factor and leukotriene B4 production in the intestine. 1998 Biol. Neonate pmid:9657667
Ahmed A et al. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. 1998 FASEB J. pmid:9657523
Rainger GE et al. Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. 1998 Thromb. Haemost. pmid:9657445
Schwartz JD et al. Cardiopulmonary bypass primes polymorphonuclear leukocytes. 1998 J. Surg. Res. pmid:9655092
Loucks EB et al. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury. 1997 Nov-Dec J Invest Surg pmid:9654389
Itadani K et al. Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands. 1998 Prostaglandins Other Lipid Mediat. pmid:9653774
Ginkgo biloba for dementia. 1998 Med Lett Drugs Ther pmid:9653424
Küçükhüseyin C et al. On the mechanisms of adenosine induced pulmonary vasoconstriction in rats. 1997 J Basic Clin Physiol Pharmacol pmid:9651801
Roudebush WE and Mathur RS Presence of platelet-activating factor in squirrel monkey (Saimiri boliviensis) spermatozoa: seasonal differences. 1998 Am. J. Primatol. pmid:9651652
Perry SW et al. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. 1998 J. Biol. Chem. pmid:9651362
Minamiya Y et al. Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9651191
Han BH et al. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study. 1998 J. Med. Chem. pmid:9651167
Shindo K et al. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients. 1998 Eur. Respir. J. pmid:9648962
Matsumoto K et al. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. 1998 J. Allergy Clin. Immunol. pmid:9648711
Watson F and Edwards SW Stimulation of primed neutrophils by soluble immune complexes: priming leads to enhanced intracellular Ca2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase. 1998 Biochem. Biophys. Res. Commun. pmid:9647777
Qayumi AK et al. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. 1998 Ann. Thorac. Surg. pmid:9647083
Shouji K et al. Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. 1998 Shock pmid:9645492
Derewenda ZS and Derewenda U The structure and function of platelet-activating factor acetylhydrolases. 1998 Cell. Mol. Life Sci. pmid:9645224
Jung KY et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. 1998 J. Nat. Prod. pmid:9644071
Botitsi E et al. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. 1998 J. Lipid Res. pmid:9643362
Mackness B et al. Lack of protection against oxidative modification of LDL by avian HDL. 1998 Biochem. Biophys. Res. Commun. pmid:9642147
Izuoka T et al. Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. 1998 Jpn. J. Physiol. pmid:9639551
Grassi S et al. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. 1998 J. Neurophysiol. pmid:9636125
Beck-Speier I et al. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence. 1998 Mar-Apr J. Biolumin. Chemilumin. pmid:9633012
Baker RR and Chang H MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. 1998 Biochim. Biophys. Acta pmid:9630721
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Spapen H et al. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock. 1998 J Crit Care pmid:9627275
Takada Y et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. 1998 Surgery pmid:9626320
Werr J et al. beta1 integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. 1998 J. Exp. Med. pmid:9625769
Gómez FP et al. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. 1998 Eur. Respir. J. pmid:9623685
Isumi H et al. Expression of a 45K subunit of platelet-activating factor acetylhydrolase in the developing mouse cerebellum. 1998 Anat. Embryol. pmid:9623676
Lapchyns'ka II [Platelet activating factor and its role in the pathogenesis of immune glomerulopathy]. 1998 Jan-Feb Lik. Sprava pmid:9621619
Lou YP et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. 1998 Am. J. Respir. Crit. Care Med. pmid:9620929
Mollinedo F et al. Physiological activation of human neutrophils down-regulates CD53 cell surface antigen. 1998 J. Leukoc. Biol. pmid:9620662
Shimada A et al. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9620295
Tsuji F and Shirasawa E The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs. 1998 Curr. Eye Res. pmid:9617545
Nakos G et al. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. 1998 Intensive Care Med pmid:9609406
Nguyen P et al. [Modulators of leukocytic functions]. 1998 J Mal Vasc pmid:9608925
ZaÄ­tseva LG et al. [The role of platelet activating factor in regulation of the phagocytic function of macrophages from different organs]. 1998 Biull Eksp Biol Med pmid:9606554
Kotelevets L et al. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion. 1998 J. Biol. Chem. pmid:9603913
O'Neill C Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. 1998 Biol. Reprod. pmid:9603268
Gómez FP et al. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. 1998 Am. J. Respir. Crit. Care Med. pmid:9603138
László F and Whittle BJ Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats. 1998 Eur. J. Pharmacol. pmid:9600654
Giménez R and Aguilar J Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats. 1998 Eur. J. Pharmacol. pmid:9600649